Iohexol: A Nonionic Contrast Medium Used for Radiographic Imaging and GFR Measurement
Iohexol is a nonionic, low-osmolality contrast medium primarily used for radiographic imaging procedures and measuring glomerular filtration rate (GFR). 1, 2
Chemical Properties and Composition
- Chemical structure: Iohexol (Chemical Abstract Services number 66108-95-0) is a triiodinated molecule with a molecular weight of 821.14 g/mol 1, 2
- Composition: Contains a benzene molecule with:
- N-(2,3-dihydroxypropyl) carbamoyl groups at positions 1 and 3
- Iodine atoms at positions 2,4, and 6
- N-(2,3-dihydroxypropyl) acetamido group at position 5 1
- Formulation: Exists as a racemic mixture of isomers (endoiohexol and exoiohexol) 1
- Commercial preparations: Available as Omnipaque or Accupaque (GE Healthcare) in various concentrations:
- Omnipaque 350: 755 mg iohexol/ml (350 mg iodine/ml)
- Omnipaque 300: 647 mg iohexol/ml (300 mg iodine/ml)
- Omnipaque 240: 518 mg iohexol/ml (240 mg iodine/ml)
- Omnipaque 180: 388 mg iohexol/ml (180 mg iodine/ml)
- Omnipaque 140: 302 mg iohexol/ml (140 mg iodine/ml) 1
Pharmacokinetics
- Distribution: After intravascular injection, iohexol distributes in the extracellular fluid compartment 2
- Metabolism: No significant metabolism, deiodination, or biotransformation occurs 2
- Excretion: Primarily excreted unchanged by glomerular filtration 2
- Approximately 90% excreted within 24 hours
- Peak urine concentrations occur within the first hour
- Renal clearance: 120 (86-162) mL/min
- Total body clearance: 131 (98-165) mL/min
- Volume of distribution: 165 (108-219) mL/kg 2
- Protein binding: Low affinity for serum or plasma proteins; poorly bound to serum albumin 2
- Placental transfer: Crosses the placental barrier in humans by simple diffusion 2, 3
Clinical Applications
1. Radiographic Imaging
- Used as a contrast agent for computed tomography (CT) scans 1, 2
- Enhances imaging through augmentation of radiographic efficiency 2
- The degree of density enhancement directly relates to iodine content 2
- Peak contrast enhancement occurs 15-120 seconds after bolus administration 2
2. GFR Measurement
- Increasingly used as an exogenous marker for measuring GFR 1, 4
- Advantages over other markers:
- Safe and inexpensive
- Non-radiolabeled
- Widely available
- Samples can be frozen and assayed at a distance 1
- Plasma clearance method does not require timed urine collection 1
- Can be accurately used for GFR measurements even in severe renal impairment (<20 ml/min) 4
Safety Profile
Adverse reactions: Lower incidence compared to ionic contrast media 5, 6, 7
- Incidence of anaphylactoid reactions approximately 1% 8
- Severe reactions occur in only about 0.04% of cases 8
- In patients with previous reactions to ionic contrast media, iohexol significantly reduces repeat reaction rates (5.5% vs 16-44%) 5
- Produces fewer deleterious hemodynamic and electrocardiographic changes than ionic agents 7
Special populations:
Important Considerations for Clinical Use
For GFR measurement:
- Standard dose: 5 ml of Omnipaque (typically 300 mg iodine/ml) 1
- Blood samples should not be frozen before centrifugation to prevent cell lysis 1
- Mild hemolysis doesn't significantly impact iohexol concentrations, but grossly hemolyzed specimens should be discarded 1
- Samples can be stored at -20°C or -80°C for delayed analysis 1
- Assays should have analytical imprecision <3% 1
Laboratory considerations:
Misconceptions:
In summary, iohexol is a versatile nonionic contrast agent with applications in both diagnostic imaging and GFR measurement, with a favorable safety profile compared to ionic contrast media.